Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (439)	12/20/2000 10:33:49 AM
From: Ben Anderson	Read Replies (2) \| Respond to of 1833

Hey Cadus followers, I am new to this company but the value play along with Icahn have my interest. Are there ways that Icahn could get whatever he wants while leaving us with shares under $1 ?? I have lots of questions but would appreciate any general info (positive and negative) about this very intriguing stock. Thanks in advance. Ben Anderson

To: tuck who wrote (439)	12/20/2000 12:59:11 PM
From: BulbaMan	Read Replies (3) \| Respond to of 1833

What would make sense for BMY is to approach Icahn and offer to sell their entire KDUS holdings all at once either to him or to Cadus itself. If Icahn said no to this offer, I'm sure they'd eventually find some hedge fund willing to buy all their shares at $1 each once the market stabilizes. Certainly BMY can wait as it doesn't need the cash. Also, imagine the bother it is to do all those SEC filings and then have itemize all the KDUS trades on BMY's tax return. Maybe I'm missing something, but I've been in the market for almost 50 years and I've rarely seen anything that appears as off-the-wall as what BMY is doing with its Cadus shares.